Equity Profile

ALKS

Alkermes plc

Health CareBiotechnology$7.0B

May5Tue

Post-Earnings Recap

ReportedQ1-2026Pre-Market7:05 AM EDT

Alkermes Beats on EPS, Stock Up 6.09%

Metric	Actual	Expected	Surprise
EPS	$-0.40	$-0.04	+30.31%
Revenue	—	$361M	—

management commentary, guidance changes, and full analysis available with Pro.

Alkermes Beats on EPS, Stock Up 6.09%

Key Numbers

Metric	Actual	Expected	Surprise
EPS	$-0.40	$-0.04	+30.31%
Revenue	—	$361M	—

Management Commentary

Tone: Unknown

No transcript is on record, so the analysis is based solely on numerical results.

What It Means

Alkermes reported a larger-than-expected loss per share, which surprised analysts. Despite the EPS miss, the stock rose by 6.09%, likely driven by investor optimism about future performance or other underlying factors not detailed in the earnings call.

Company Snapshot

Alkermes plc is a biotechnology company focused on developing innovative medicines for people with serious mental health conditions and addiction. Operating in the health care sector, Alkermes plays a crucial role in addressing unmet medical needs through its research and development efforts.

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and helps investors gauge the company's financial health.

$-0.04

Revenue

Revenue figures provide insight into the company's sales performance and market demand for its products.

$361M

Wall Street expectations, options signals, track record, and call prep available with Pro.

Original Pre-Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+20.09%

Avg Stock Reaction

+2.52%

Last Quarter Recap

In Q4 2025, Alkermes reported an EPS of $0.29, slightly missing expectations. The stock reacted negatively, dropping 7.04% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect Alkermes to report a loss this quarter, with a consensus EPS of $-0.04 and revenue of $361 million. The market is cautious given the company's recent performance.

Bull Case

If Alkermes can exceed revenue expectations and show signs of improved profitability, it could boost investor confidence and lead to a positive stock reaction.

Bear Case

A continued trend of missing earnings expectations could further erode investor trust and lead to a significant decline in stock price.

Key Metrics to Watch

EPS

$-0.04

Earnings per share is a key indicator of profitability and helps investors gauge the company's financial health.

Revenue

$361M

Revenue figures provide insight into the company's sales performance and market demand for its products.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Alkermes report revenue above the consensus estimate of $361 million?

Exceeding revenue expectations could signal strong demand for its products and improve investor sentiment.

How will management address the recent trend of missing EPS expectations?

Investors will be looking for reassurances or strategies to improve profitability moving forward.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate the potential for Alkermes to surprise on revenue, as recent product launches could drive higher sales than anticipated.

Supporting Evidence

The company's innovative pipeline may yield unexpected revenue growth.

Options pricing suggests traders are anticipating a larger move than historical averages, indicating potential for a surprise.

Key Risk

If revenue exceeds $379 million, it could challenge the bearish outlook and shift sentiment positively.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is critical as it follows a history of mixed earnings results, and investor expectations are cautious.

Bull Confirmed If

A revenue figure above $361 million would confirm the bull case and suggest strong market performance.

Bear Confirmed If

An EPS loss greater than the consensus of $-0.04 would validate the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±8.59%

Historical Avg

±5.2%

Pricing rich

The options market is pricing in a significant move, indicating that traders expect volatility around the earnings announcement.

Options are pricing ±7.6% while ALKS has averaged ±5.2% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.6%

30d HV

56.8%

Calls (8K)P/C Ratio: 1.38Puts (12K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Alkermes beats expectations, history suggests the stock could rise by about 2.97%, confirming a positive turnaround.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further clarity from management.

Miss

A miss could lead to a decline, with historical averages suggesting a drop of around 0.97%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on product launches and their expected impact on revenue.
2Management's commentary on strategies to improve profitability.
3Insights into market demand for Alkermes' key products.
4Discussion on any regulatory developments affecting the company.
5Future guidance on revenue and EPS expectations.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

May4

GRABReported

Grab Holdings Limited

RecapView

May4

GBDCReported

Company Snapshot

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and helps investors gauge the company's financial health.

$-0.04

Revenue

Revenue figures provide insight into the company's sales performance and market demand for its products.

$361M

Wall Street expectations, options signals, track record, and call prep available with Pro.

Original Pre-Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+20.09%

Avg Stock Reaction

+2.52%

Last Quarter Recap

In Q4 2025, Alkermes reported an EPS of $0.29, slightly missing expectations. The stock reacted negatively, dropping 7.04% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect Alkermes to report a loss this quarter, with a consensus EPS of $-0.04 and revenue of $361 million. The market is cautious given the company's recent performance.

Bull Case

If Alkermes can exceed revenue expectations and show signs of improved profitability, it could boost investor confidence and lead to a positive stock reaction.

Bear Case

A continued trend of missing earnings expectations could further erode investor trust and lead to a significant decline in stock price.

Key Metrics to Watch

EPS

$-0.04

Earnings per share is a key indicator of profitability and helps investors gauge the company's financial health.

Revenue

$361M

Revenue figures provide insight into the company's sales performance and market demand for its products.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Alkermes report revenue above the consensus estimate of $361 million?

Exceeding revenue expectations could signal strong demand for its products and improve investor sentiment.

How will management address the recent trend of missing EPS expectations?

Investors will be looking for reassurances or strategies to improve profitability moving forward.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate the potential for Alkermes to surprise on revenue, as recent product launches could drive higher sales than anticipated.

Supporting Evidence

The company's innovative pipeline may yield unexpected revenue growth.

Options pricing suggests traders are anticipating a larger move than historical averages, indicating potential for a surprise.

Key Risk

If revenue exceeds $379 million, it could challenge the bearish outlook and shift sentiment positively.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is critical as it follows a history of mixed earnings results, and investor expectations are cautious.

Bull Confirmed If

A revenue figure above $361 million would confirm the bull case and suggest strong market performance.

Bear Confirmed If

An EPS loss greater than the consensus of $-0.04 would validate the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±8.59%

Historical Avg

±5.2%

Pricing rich

The options market is pricing in a significant move, indicating that traders expect volatility around the earnings announcement.

Options are pricing ±7.6% while ALKS has averaged ±5.2% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.6%

30d HV

56.8%

Calls (8K)P/C Ratio: 1.38Puts (12K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Alkermes beats expectations, history suggests the stock could rise by about 2.97%, confirming a positive turnaround.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further clarity from management.

Miss

A miss could lead to a decline, with historical averages suggesting a drop of around 0.97%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on product launches and their expected impact on revenue.
2Management's commentary on strategies to improve profitability.
3Insights into market demand for Alkermes' key products.
4Discussion on any regulatory developments affecting the company.
5Future guidance on revenue and EPS expectations.